Search clinical trials for: HTL0018318

Total 4 results

Heptares Therapeutics Limited
Sosei

Withdrawn

A Study to Assess Safety, Tolerability, and Efficacy of HTL0018318 in Patients With Dementia With Lewy Bodies (DLB)

Dementia With Lewy Bodies

Japan
Heptares Therapeutics Limited
Allergan

Completed

Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care

Alzheimer's Disease

Czechia, Poland, Slovakia, Spain
Heptares Therapeutics Limited

Completed

Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects (HTL0018318)

Pharmacokinetics | Safety Issues

United Kingdom
Heptares Therapeutics Limited

Completed

Relative Bioavailability of HTL0018318 Oral Aqueous Solution Versus Capsules

Bioavailability and Pharmacokinetics

United Kingdom

3

Subscribe